STL Index for: Ciclopirox
Efinaconazole in the Treatment of Onychomycosis: Managing Patient Expectations and Promoting Compliance
Onychomycosis, also known as tinea unguium, is a progressive fungal infection of the nails resulting in discoloration, nail plate thickening, and onycholysis. Efinaconazole 10% solution is an effective and convenient topical antifungal treatment for onychomycosis, with toenail mycological cure rates between 53.4% and 55.2% and complete cure rates between 15.2% and 17.8%.
Topical Efinaconazole in the Management of Toenail Onychomycosis
Onychomycosis is a fungal infection of the nail caused by dermatophytes, yeasts, or non-dermatophyte molds. Here we discuss using topical Efinaconazole in the management of toenail onychomycosis.
Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis
Update and discussion on onychomycosis (nail fungus) and Efinaconazole 10%. Recent clinical trial results, and discussion about patient safety profile, special cases like diabetic patients, and cure rates.
Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis
Onychomycosis is a stubborn fungal infection of the nails that can be difficult to manage. Clinical trial data of Tavaborole is considered, as it allows for effective nail penetration compared to ciclopirox and amorolfine lacquers.
Onychomycosis Diagnosis and Emerging Therapy
Onychomycosis is a common nail disorder for which successful treatment can be clinically challenging. Diagnosis, treatment, and management using various modalities are discussed.
Efinaconazole: A New Topical Treatment for Onychomycosis
Nail fungus, left untreated, the infection can spread to other nails and potentially cause further complications. This article reviews efinaconazole 10% as a topical monotherapy. Clinical trial data, mechanism of action, and future treatments are discussed.
Therapeutic Update on Seborrheic Dermatitis
Seborrheic dermatitis is a recurrent, usually mild, skin disorder with typical clinical manifestations. This article will review the available treatments for this common dermatologic problem.
Ciclopirox
Ciclopirox olamine is a hydroxypyridone antifungal that is used to treat fungal infections. Indication, brand names, therapeutic regimen, and safety information are discussed.
Penlac® (Ciclopirox) Overview
Penlac (Ciclopirox), and its pharmacokinetics, delivery system, safety, and patient selection are discussed. Monotherapy and combination therapy and its patient criteria are discussed.
Seborrheic Dermatitis: New Formulations for Treatment
Seborrheic dermatitis is a common cutaneous disorder occurring in at least 3%–5% of the population. We discuss new treatment formulations and protocols.
Practical Management Strategies for Diaper Dermatitis
Common diaper dermatitis is an irritant contact diaper dermatitis (IDD) created by the combined influence of moisture, warmth, urine, feces, friction, and secondary infection. This article will focus on practical management strategies for IDD.
Scaly Rashes of the Feet: Could It Be Fungal?
This article will deal with the diagnosis and treatment of common eruptions on the feet.
Management of Onychomycosis
Diagnosis of onychomycosis can only be established with a positive culture or observation of fungus in the nail clippings. Consideration should be given to cost and possible complications before starting treatment. Recurrent disease is a problem even after a complete cure.
Ciclopirox Nail Lacquer 8% for the Treatment of Onychomycosis: A Canadian Perspective
Onychomycosis is prevalent, and risk factors, such as old age and diabetes, are increasing. This condition has been treated using oral antifungal agents with varying degrees of success. Recently, ciclopirox nail lacquer 8% solution became the first topical agent approved in Canada for onychomycosis.
Ciclopirox (Loprox®) Gel for Superficial Fungal Infections
Ciclopirox (Loprox®) is a broad-spectrum antifungal medication that also has antibacterial and anti-inflammatory properties. Ciclopirox is indicated in the US for the treatment of tinea pedis, tinea corporis, pityriasis versicolor, seborrheic dermatitis, and cutaneous candidiasis.
Ciclopirox Shampoo for Treating Seborrheic Dermatitis
Seborrheic dermatitis is a common inflammatory skin disease, affecting between 1% and 3% of immunocompetent adults. While its cause is unknown, a number of predisposing factors have been reported, including the implications of Malassezia yeasts.
Ciclopirox Nail Lacquer Topical Solution 8%
Ciclopirox nail lacquer 8% (Penlac, Aventis Pharma) was approved by the US FDA in December 1999, as a component of a comprehensive management program, for use in immunocompetent patients who have mild to moderate onychomycosis of the fingers and toes without lunula involvement due to Trichophyton rubrum.